Literature DB >> 3195622

Case report: dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.

R C Wille1, J D Morrow.   

Abstract

Dapsone (4-4-diaminodiphenyl-sulfone) is a member of the sulfone group of antibiotics used in the treatment of leprosy and various dermatitidies and more recently employed in the management of local reactions to the bite of the brown recluse spider, Loxosceles reclusa. A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy. A case report of the hypersensitivity syndrome occurring in a patient being treated with dapsone for a brown recluse spider bite is presented.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3195622     DOI: 10.1016/s0002-9629(15)40859-6

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Odontoid osteomyelitis. An unusual presentation of an uncommon disease.

Authors:  J Ruskin; S Shapiro; M McCombs; H Greenberg; E Helmer
Journal:  West J Med       Date:  1992-03

Review 2.  The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.

Authors:  J Mohle-Boetani; S K Akula; M Holodniy; D Katzenstein; G Garcia
Journal:  West J Med       Date:  1992-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.